Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE American: SENS) plans to present at the Inaugural Gilmartin Group Emerging Showcase virtually on August 31, 2022, at 3:00pm ET. The company specializes in developing long-term, implantable continuous glucose monitoring systems for diabetes management. Interested parties can access a live and archived webcast of the presentation on the company’s website at www.senseonics.com. The Eversense® CGM systems provide real-time glucose data through a small sensor under the skin, enhancing diabetes care.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, 2022 at 3:00pm ET.

Interested parties can access a live and recorded webcast presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of the company’s website at www.senseonics.com.

Those parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense^®, Eversense^® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220817005639/en/

Senseonics Investor Contact

Philip Taylor

Investor Relations

415-937-5406

investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

What is Senseonics' presentation schedule at the Gilmartin Group Emerging Showcase?

Senseonics Holdings, Inc. will present on August 31, 2022, at 3:00pm ET.

How can I access the Senseonics presentation webcast?

You can access the live and archived webcast of Senseonics' presentation on their website at www.senseonics.com.

What are the features of the Eversense CGM systems by Senseonics?

Eversense CGM systems include a small sensor implanted under the skin that sends glucose data to a smart transmitter, updating every 5 minutes.

What does Senseonics focus on in the medical technology industry?

Senseonics focuses on developing long-term, implantable continuous glucose monitoring systems for diabetes management.